Aldeyra Therapeutics, Inc. News Headlines

ALDX 
$4.27
*  
0.02
0.47%
Get ALDX Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading ALDX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALDX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Sector Update: Healthcare Stocks Inching Higher; Aldeyra Therapeutics Near Record High After Aegis Starts Coverage with Buy Rating
6/19/2014 1:16:57 PM - MT Newswires

Sector Update: Healthcare
6/19/2014 1:15:25 PM - MT Newswires

Aldeyra Therapeutics Appoints Stephen Tulipano As CFO - Quick Facts
6/19/2014 8:49:00 AM - RTT News

Aldeyra Therapeutics prices IPO at $8, below the range
5/2/2014 8:20:09 AM - Renaissance Capital

4 U.S. IPOs Planned For The Week Of April 28
4/29/2014 8:28:00 AM - Seeking Alpha

4 US IPOs planned for the week of Apr 28
4/28/2014 8:00:03 AM - Renaissance Capital

Rare disease biotech Aldeyra Therapeutics cuts proposed IPO deal size by 47%
4/25/2014 5:05:51 PM - Renaissance Capital

Aldeyra Therapeutics IPO Looks Less Curative Than It Should
4/23/2014 7:26:00 AM - Seeking Alpha

4 U.S. IPOs Planned For The Week Of April 21
4/22/2014 12:59:00 PM - Seeking Alpha

4 US IPOs planned for the week of Apr 21
4/21/2014 8:00:04 AM - Renaissance Capital

IPO Preview: Aldeyra Therapeutics
4/11/2014 1:11:00 AM - Seeking Alpha

16 U.S. IPOs Planned For The Week Of April 7
4/8/2014 8:19:00 AM - Seeking Alpha

16 US IPOs planned for the week of Apr 7
4/7/2014 11:54:23 AM - Renaissance Capital

U.S. IPO Recap: Year's Largest Biotech IPO Versartis Jumps 49% Amid Tech-Biotech Frenzy
3/24/2014 3:07:00 PM - Seeking Alpha

Rare disease biotech Aldeyra Therapeutics increases shares offered, deal size is now $25 million
3/21/2014 3:26:58 PM - Renaissance Capital

Rare disease biotech Aldeyra Therapeutics sets terms for $22 million IPO
3/17/2014 6:26:55 PM - Renaissance Capital

U.S. IPO Recap: 20 Companies File Or Set Terms For IPOs
1/14/2014 7:31:00 AM - Seeking Alpha